The multi-product oncology deal includes assets that have validated targets and aim to address efficacy and/or tolerability limitations of existing therapies.
With expertise in traditional and advanced therapies, Cardinal Health Regulatory Sciences will collaborate throughout the product lifecycle to help achieve your regulatory goals. Learn more.
